OpenAI has agreed to acquire Astral, a startup behind widely used Python development tools, in a deal designed to sharpen its Codex coding assistant as competition with Anthropic intensifies. The ...

OpenAI Group PBC today announced plans to acquire Astral Software Inc., a startup with a set of widely used Python development tools.  The terms of the deal were not disclosed. Astral’s development ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

The deal, whose financial terms were not disclosed, is subject to customary closing conditions, including regulatory approvals. Until the transaction closes, the companies will continue to operate ...

UC San Diego cognitive scientist Philip Guo created Python Tutor, a free tool that makes code “visible” step by step. The research behind it earned a Test of Time award, recog ...

Enterprise AI doesn’t prove its value through pilots, it proves it through disciplined financial modeling. Here’s how ESG quantified productivity gains, faster deployment, operational efficiency, and ...

JetBrains, the company behind the popular PyCharm IDE, offers a free introductory Python course. This is a pretty neat option if you like learning by doing, especially within a professional coding ...

Machine learning is an essential component of artificial intelligence. Whether it’s powering recommendation engines, fraud detection systems, self-driving cars, generative AI, or any of the countless ...

The LGC Faster Rail project will improve access to frequent trains with upgraded stations and better walking and cycling links. Credit: ACCIONA. Acciona, as a member of the ActivUs consortium, has ...

In this tutorial, we build an end-to-end cognitive complexity analysis workflow using complexipy. We start by measuring complexity directly from raw code strings, then scale the same analysis to ...

The Digital Medicine Society (DiME) has launched a new set of digital clinical measures to accelerate the development of pediatric rare disease treatments in collaboration with partners including the ...